{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:09:21Z","timestamp":1794834561739,"version":"4.9.1"},"reference-count":87,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,23]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Venous thromboembolism (VTE) is a significant cause of morbidity in children, particularly among hospitalized patients and those with chronic medical conditions. There is a lack of consensus on anticoagulant prophylaxis strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>These evidence-based guidelines from the American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH) are intended to support patients and health care professionals in decisions about anticoagulant prophylaxis for pediatric VTE prevention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>ASH formed a multidisciplinary guideline panel that included 1 patient representative. The University of Kansas Health System supported the guideline development process, including systematic evidence reviews up to April 2025. Clinical questions and outcomes were prioritized according to their importance for clinicians and patients. The panel used the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach to assess certainty in the evidence and make recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The panel agreed on 12 recommendations. For pediatric patients with solid cancer, who have experienced trauma, or who are critically ill, the panel issued conditional recommendations suggesting no anticoagulant prophylaxis. For pediatric patients with antiphospholipid antibody syndrome, or those on long-term total parenteral nutrition, the panel issued conditional recommendations suggesting the use of anticoagulant prophylaxis. Other pediatric subgroups addressed included patients with acute lymphoblastic leukemia or lymphoma, surgical and hospitalized patients, and those with a central venous access device.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>High-quality data on anticoagulant prophylaxis for pediatric VTE prevention are scarce. Key research priorities include the development and validation of subgroups-specific VTE risk assessment models, and evaluation of the safety and efficacy of risk-stratified anticoagulant prophylaxis strategies across different pediatric subgroups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025019415","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T14:01:48Z","timestamp":1775656908000},"page":"4303-4333","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":15,"title":["ASH\/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6725-3035","authenticated-orcid":false,"given":"Marisol","family":"Betensky","sequence":"first","affiliation":[{"name":"1Division of Hematology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD"},{"name":"2Division of Hematology, Cancer and Blood Disorders Institute, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2046-8343","authenticated-orcid":false,"given":"Muayad","family":"Azzam","sequence":"additional","affiliation":[{"name":"3Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6653-5946","authenticated-orcid":false,"given":"Rachel","family":"Bercovitz","sequence":"additional","affiliation":[{"name":"4Division of Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1700-4804","authenticated-orcid":false,"given":"Rukhmi V.","family":"Bhat","sequence":"additional","affiliation":[{"name":"4Division of Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9986-4973","authenticated-orcid":false,"given":"Tina","family":"Biss","sequence":"additional","affiliation":[{"name":"5Department of Haematology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4076-270X","authenticated-orcid":false,"given":"Brian","family":"Branchford","sequence":"additional","affiliation":[{"name":"6Division of Hematology, Department of Pediatrics, Medical College of Wisconsin, Wauwatosa, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7711-4530","authenticated-orcid":false,"given":"Leonardo R.","family":"Brand\u00e3o","sequence":"additional","affiliation":[{"name":"7Division of Hematology\/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1551-3995","authenticated-orcid":false,"given":"Anthony K. C.","family":"Chan","sequence":"additional","affiliation":[{"name":"8Division Pediatric Hematology\/Oncology, Department of Pediatrics, McMaster Children\u2019s Hospital, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6155-2691","authenticated-orcid":false,"given":"E.","family":"Vincent S. Faustino","sequence":"additional","affiliation":[{"name":"9Department of Pediatrics, Section of Critical Care, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9711-4650","authenticated-orcid":false,"given":"Qais","family":"Hamarsha","sequence":"additional","affiliation":[{"name":"3Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1175-7266","authenticated-orcid":false,"given":"Julie","family":"Jaffray","sequence":"additional","affiliation":[{"name":"10Division of Hematology\/Oncology, Department of Pediatrics, Rady Children's Hospital-San Diego, San Diego, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9272-6540","authenticated-orcid":false,"given":"Sophie","family":"Jones","sequence":"additional","affiliation":[{"name":"11Faculty of Medicine, Dentistry and Health Sciences, Department of Nursing, Royal Children\u2019s Hospital, University of Melbourne, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3725-8485","authenticated-orcid":false,"given":"Hassan","family":"Kawtharany","sequence":"additional","affiliation":[{"name":"3Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1756-8271","authenticated-orcid":false,"given":"Bryce A.","family":"Kerlin","sequence":"additional","affiliation":[{"name":"12Division of Pediatric Hematology\/Oncology\/BMT, Department of Pediatrics, Nationwide Children\u2019s Hospital, The Ohio State University College of Medicine, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7581-4787","authenticated-orcid":false,"given":"Jana","family":"Khawandi","sequence":"additional","affiliation":[{"name":"3Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Krider","sequence":"additional","affiliation":[{"name":"13Department of Nursing, Ascension St. Vincent Indianapolis, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4865-4033","authenticated-orcid":false,"given":"Nicole","family":"Kucine","sequence":"additional","affiliation":[{"name":"14Division of Hematology\/Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8004-4190","authenticated-orcid":false,"given":"Riten","family":"Kumar","sequence":"additional","affiliation":[{"name":"15Department of Pediatrics, Dana Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4989-6421","authenticated-orcid":false,"given":"Christoph","family":"Male","sequence":"additional","affiliation":[{"name":"16Department of Paediatrics, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3970-8984","authenticated-orcid":false,"given":"Paul","family":"Monagle","sequence":"additional","affiliation":[{"name":"17Department of Pediatrics, Royal Children\u2019s Hospital, University of Melbourne, Melbourne, VIC, Australia"},{"name":"18Faculty of Medicine, Dentistry and Health Sciences, Sydney Children\u2019s Hospital, Randwick NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2364-7205","authenticated-orcid":false,"given":"Marie-Claude","family":"Pelland-Marcotte","sequence":"additional","affiliation":[{"name":"19Department of Pediatrics, Centre Hospitalier Universitaire de Qu\u00e9bec, Centre M\u00e8re-Enfant, Qu\u00e9bec City, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-1040","authenticated-orcid":false,"given":"Leslie","family":"Raffini","sequence":"additional","affiliation":[{"name":"20Division of Hematology, Department of Pediatrics, University of Pennsylvania, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7610-7214","authenticated-orcid":false,"given":"Chittalsinh","family":"Raulji","sequence":"additional","affiliation":[{"name":"21Division of Hematology\/Oncology, Department of Pediatrics, University of Nebraska Medical Center, Children\u2019s Hospital Nebraska, Omaha, NE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2204-4568","authenticated-orcid":false,"given":"Sarah E.","family":"Sartain","sequence":"additional","affiliation":[{"name":"22Section of Hematology, Department of Pediatrics, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2832-6884","authenticated-orcid":false,"given":"Clifford M.","family":"Takemoto","sequence":"additional","affiliation":[{"name":"23Department of Hematology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0283-9972","authenticated-orcid":false,"given":"Cristina","family":"Tarango","sequence":"additional","affiliation":[{"name":"24Division of Hematology, Department of Pediatrics, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9036-039X","authenticated-orcid":false,"given":"C.","family":"Heleen van Ommen","sequence":"additional","affiliation":[{"name":"25Department of Pediatric Hematology, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9426-4075","authenticated-orcid":false,"given":"Maria C.","family":"Velez","sequence":"additional","affiliation":[{"name":"26Division of Hematology\/Oncology, Department of Pediatrics, Louisiana State University Health Sciences Center\/Children\u2019s Hospital New Orleans, New Orleans, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3448-0156","authenticated-orcid":false,"given":"Sara K.","family":"Vesely","sequence":"additional","affiliation":[{"name":"27Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences, Hudson College of Public Health, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5058-3596","authenticated-orcid":false,"given":"John","family":"Wiernikowski","sequence":"additional","affiliation":[{"name":"28Division of Hematology\/Oncology, Department of Pediatrics, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9321-4301","authenticated-orcid":false,"given":"Suzan","family":"Williams","sequence":"additional","affiliation":[{"name":"7Division of Hematology\/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8904-3338","authenticated-orcid":false,"given":"Hope P.","family":"Wilson","sequence":"additional","affiliation":[{"name":"29Division of Hematology\/Oncology, Department of Pediatrics, Children\u2019s of Alabama, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0921-0974","authenticated-orcid":false,"given":"Gary","family":"Woods","sequence":"additional","affiliation":[{"name":"30Division of Hematology\/Oncology, Department of Pediatrics, Children\u2019s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2091-0875","authenticated-orcid":false,"given":"Reem A.","family":"Mustafa","sequence":"additional","affiliation":[{"name":"31Division of Nephrology, Department of Internal Medicine, Evidence-based Practice and Impact Center, The University of Kansas Health System, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"7","key":"2026062308463852200_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-156-7-201204030-00009","article-title":"Guidelines International Network: toward international standards for clinical practice guidelines","volume":"156","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med"},{"issue":"7","key":"2026062308463852200_bib2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/M14-1885","article-title":"Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines","volume":"163","author":"Sch\u00fcnemann","year":"2015","journal-title":"Ann Intern Med"},{"key":"2026062308463852200_bib3","author":"Graham","year":"2011"},{"key":"2026062308463852200_bib4","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"2026062308463852200_bib5","doi-asserted-by":"crossref","first-page":"i2016","DOI":"10.1136\/bmj.i2016","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"2026062308463852200_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6963-4-38","article-title":"Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group","volume":"4","author":"Atkins","year":"2004","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"2026062308463852200_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"7650","key":"2026062308463852200_bib8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"2026062308463852200_bib9","first-page":"677","article-title":"Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations","volume":"169","author":"Sch\u00fcnemann","year":"2003","journal-title":"CMAJ"},{"key":"2026062308463852200_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jclinepi.2016.01.032","article-title":"GRADE guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health","volume":"76","author":"Sch\u00fcnemann","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"2026062308463852200_bib11","doi-asserted-by":"crossref","first-page":"e2021054649","DOI":"10.1542\/peds.2021-054649","article-title":"The continued rise of venous thromboembolism across US children's hospitals","volume":"149","author":"O'Brien","year":"2022","journal-title":"Pediatrics"},{"key":"2026062308463852200_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpeds.2016.02.017","article-title":"Incidence trends and mortality from childhood venous thromboembolism: a population-based cohort study","volume":"172","author":"Sabapathy","year":"2016","journal-title":"J Pediatr"},{"issue":"2","key":"2026062308463852200_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jtha.2024.09.038","article-title":"Duration of anticoagulation for venous thromboembolism in pediatric patients: evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years","volume":"23","author":"Goldenberg","year":"2025","journal-title":"J Thromb Haemost"},{"key":"2026062308463852200_bib14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.thromres.2018.02.010","article-title":"Pediatric issues in thrombosis and hemostasis: the how and why of venous thromboembolism risk stratification in hospitalized children","volume":"172","author":"Branchford","year":"2018","journal-title":"Thromb Res"},{"issue":"22","key":"2026062308463852200_bib15","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"issue":"10","key":"2026062308463852200_bib16","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/jth.12372","article-title":"Developmental hemostasis: age-specific differences in the levels of hemostatic proteins","volume":"11","author":"Attard","year":"2013","journal-title":"J Thromb Haemost"},{"key":"2026062308463852200_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jpeds.2020.09.016","article-title":"Development of a risk model for pediatric hospital-acquired thrombosis: a report from the Children's Hospital-Acquired Thrombosis Consortium","volume":"228","author":"Jaffray","year":"2021","journal-title":"J Pediatr"},{"issue":"3","key":"2026062308463852200_bib18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jth.14697","article-title":"Comparative validation study of risk assessment models for pediatric hospital-acquired venous thromboembolism","volume":"18","author":"Mahajerin","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2026062308463852200_bib19","doi-asserted-by":"crossref","first-page":"e12793","DOI":"10.1002\/rth2.12793","article-title":"Current practices in pediatric hospital-acquired thromboembolism: survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium","volume":"6","author":"Abrams","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"2026062308463852200_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/ejvs.2001.1348","article-title":"Intermittent pneumatic compression devices\u2013physiological mechanisms of action","volume":"21","author":"Chen","year":"2001","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"2026062308463852200_bib21","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1055\/s-0040-1710016","article-title":"Haematological effects of intermittent pneumatic compression for deep vein thrombosis prophylaxis","volume":"120","author":"Morris","year":"2020","journal-title":"Thromb Haemost"},{"issue":"1","key":"2026062308463852200_bib22","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1097\/PCC.0000000000003601","article-title":"Mechanical thromboprophylaxis and hospital-acquired venous thromboembolism among critically ill adolescents: a US Pediatric Health Information Systems Registry Study, 2016-2023","volume":"26","author":"Betensky","year":"2025","journal-title":"Pediatr Crit Care Med"},{"key":"2026062308463852200_bib23","first-page":"1097","article-title":"Thromboprophylaxis for critically ill adolescents: a multicenter case-control study from the Children\u2019s Healthcare Advancements in Thrombosis Consortium","volume":"10","author":"Vallabhaneni","year":"2025","journal-title":"Pediatr Crit Care Med"},{"key":"2026062308463852200_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jclinepi.2016.07.006","article-title":"Fs should seldom make good practice statements: guidance from the GRADE Working Group","volume":"80","author":"Guyatt","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"2026062308463852200_bib25","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jtha.2023.03.004","article-title":"Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis","volume":"21","author":"Whitworth","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2026062308463852200_bib26","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1503\/cmaj.131237","article-title":"Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise","volume":"186","author":"Sch\u00fcnemann","year":"2014","journal-title":"Cmaj"},{"key":"2026062308463852200_bib27","author":"Bro\u017cek","year":"2014"},{"issue":"4","key":"2026062308463852200_bib28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"2026062308463852200_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jclinepi.2021.02.026","article-title":"GRADE notes: how to use GRADE when there is \u201cno\u201d evidence? A case study of the expert evidence approach","volume":"137","author":"Mustafa","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"2026062308463852200_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3324\/haematol.2018.194175","article-title":"THROMBOTECT-a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents","volume":"104","author":"Greiner","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"2026062308463852200_bib31","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/S2352-3026(23)00314-9","article-title":"Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial","volume":"11","author":"O'Brien","year":"2024","journal-title":"Lancet Haematol"},{"issue":"10","key":"2026062308463852200_bib32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1055\/a-2316-4547","article-title":"Thrombin generation profile using ST-Genesia after PEG-asparaginase in pediatric patients with acute lymphoblastic leukemia","volume":"124","author":"Ruiz-Llobet","year":"2024","journal-title":"Thromb Haemost"},{"issue":"5","key":"2026062308463852200_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00001721-200107000-00005","article-title":"Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia","volume":"12","author":"Elhasid","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"24","key":"2026062308463852200_bib34","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1182\/blood-2010-01-263012","article-title":"Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study","volume":"115","author":"Mitchell","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2026062308463852200_bib35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/cncr.11042","article-title":"A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) study","volume":"97","author":"Mitchell","year":"2003","journal-title":"Cancer"},{"issue":"1-2","key":"2026062308463852200_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0609.1996.tb00290.x","article-title":"Inhibition of hypercoagulation by antithrombin substitution in E. coli L-asparaginase-treated children","volume":"56","author":"Nowak-G\u00f6ttl","year":"1996","journal-title":"Eur J Haematol"},{"issue":"2","key":"2026062308463852200_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/0267659120939758","article-title":"Antithrombin use during pediatric cardiac extracorporeal membrane oxygenation admission: insights from a national database","volume":"36","author":"Aiello","year":"2021","journal-title":"Perfusion"},{"issue":"4","key":"2026062308463852200_bib38","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/NCC.0b013e31829627e7","article-title":"Analysis of risk factors for central venous catheter-related complications: a prospective observational study in pediatric patients with bone sarcomas","volume":"37","author":"Abate","year":"2014","journal-title":"Cancer Nurs"},{"key":"2026062308463852200_bib39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.thromres.2017.02.011","article-title":"Venous thrombosis in children and adolescents with Hodgkin lymphoma in Sweden","volume":"152","author":"Sch\u00f6nning","year":"2017","journal-title":"Thromb Res"},{"issue":"12","key":"2026062308463852200_bib40","doi-asserted-by":"crossref","first-page":"e29360","DOI":"10.1002\/pbc.29360","article-title":"Primary thromboprophylaxis to prevent thrombotic events in pediatric oncology patients with a malignant mediastinal mass","volume":"68","author":"Sarangi","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"2026062308463852200_bib41","doi-asserted-by":"crossref","first-page":"109287","DOI":"10.1016\/j.thromres.2025.109287","article-title":"Venous thromboembolism in children with Hodgkin lymphoma - a population-based study in Sweden, Finland, and Denmark","volume":"248","author":"Giertz","year":"2025","journal-title":"Thromb Res"},{"issue":"9","key":"2026062308463852200_bib42","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/08035250600729092","article-title":"Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study","volume":"95","author":"Ruud","year":"2006","journal-title":"Acta Paediatr"},{"key":"2026062308463852200_bib43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clnu.2025.01.023","article-title":"Prophylactic anticoagulation in children receiving home parenteral nutrition: an international prospective multicenter study","volume":"46","author":"Demirok","year":"2025","journal-title":"Clin Nutr"},{"issue":"4","key":"2026062308463852200_bib44","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/0148607111416482","article-title":"Prophylactic anticoagulation decreases catheter-related thrombosis and occlusion in children with home parenteral nutrition","volume":"36","author":"Vegting","year":"2012","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"3","key":"2026062308463852200_bib45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0022-3476(95)70448-5","article-title":"A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home","volume":"126","author":"Andrew","year":"1995","journal-title":"J Pediatr"},{"issue":"5","key":"2026062308463852200_bib46","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/jpen.2298","article-title":"Prophylactic anticoagulation in children receiving home parenteral nutrition","volume":"46","author":"Nagelkerke","year":"2022","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"6 pt B","key":"2026062308463852200_bib47","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.clnu.2018.06.952","article-title":"ESPGHAN\/ESPEN\/ESPR\/CSPEN guidelines on pediatric parenteral nutrition: venous access","volume":"37","author":"Kola\u010dek","year":"2018","journal-title":"Clin Nutr"},{"issue":"4","key":"2026062308463852200_bib48","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jtcvs.2020.12.102","article-title":"Long-term outcomes of warfarin versus aspirin after Fontan surgery","volume":"162","author":"Attard","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"2026062308463852200_bib49","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1203\/01.PDR.0000155943.07244.04","article-title":"Reduced bone density in children on long-term warfarin","volume":"57","author":"Barnes","year":"2005","journal-title":"Pediatr Res"},{"issue":"8","key":"2026062308463852200_bib50","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s11606-016-3603-8","article-title":"Effects of long-term low-molecular-weight heparin on fractures and bone density in non-pregnant adults: a systematic review with meta-analysis","volume":"31","author":"Gajic-Veljanoski","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"suppl 1","key":"2026062308463852200_bib51","first-page":"S9","article-title":"Definition, classification, and causes of short bowel syndrome","volume":"38","author":"Pironi","year":"2023","journal-title":"Nutr Clin Pract"},{"issue":"3","key":"2026062308463852200_bib52","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1097\/CCM.0000000000004784","article-title":"Efficacy of early prophylaxis against catheter-associated thrombosis in critically ill children: a Bayesian phase 2b randomized clinical trial","volume":"49","author":"Faustino","year":"2021","journal-title":"Crit Care Med"},{"issue":"2","key":"2026062308463852200_bib53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jpeds.2012.06.059","article-title":"Incidence and acute complications of asymptomatic central venous catheter-related deep venous thrombosis in critically ill children","volume":"162","author":"Faustino","year":"2013","journal-title":"J Pediatr"},{"issue":"8","key":"2026062308463852200_bib54","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1182\/blood-2018-05-849737","article-title":"The natural history of asymptomatic central venous catheter-related thrombosis in critically ill children","volume":"133","author":"Jones","year":"2019","journal-title":"Blood"},{"issue":"1","key":"2026062308463852200_bib55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jtha.2023.09.023","article-title":"Antithrombin activity and central venous catheter-associated thrombosis in critically ill children at high risk of bleeding","volume":"22","author":"Quinn","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2026062308463852200_bib56","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/1043454210369895","article-title":"Observational cohort study of pediatric inpatients with central venous catheters at \u201cintermediate risk\u201d of thrombosis and eligible for anticoagulant prophylaxis","volume":"27","author":"Harney","year":"2010","journal-title":"J Pediatr Oncol Nurs"},{"issue":"2-3","key":"2026062308463852200_bib57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(03)00099-9","article-title":"An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thromb Res"},{"issue":"3","key":"2026062308463852200_bib58","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood.2021013453","article-title":"Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis","volume":"139","author":"Clark","year":"2022","journal-title":"Blood"},{"issue":"5","key":"2026062308463852200_bib59","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s10067-017-3776-5","article-title":"Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients","volume":"37","author":"Ma","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"3","key":"2026062308463852200_bib60","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/MBC.0000000000000576","article-title":"A retrospective review of pediatric antiphospholipid syndrome and thrombosis outcomes","volume":"28","author":"Rao","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"2026062308463852200_bib61","doi-asserted-by":"crossref","first-page":"e1100","DOI":"10.1542\/peds.2008-1209","article-title":"Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry","volume":"122","author":"Avcin","year":"2008","journal-title":"Pediatrics"},{"issue":"22","key":"2026062308463852200_bib62","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1182\/bloodadvances.2021005681","article-title":"Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia","volume":"6","author":"Brand\u00e3o","year":"2022","journal-title":"Blood Adv"},{"issue":"7","key":"2026062308463852200_bib63","doi-asserted-by":"crossref","first-page":"E268","DOI":"10.1002\/ajh.26565","article-title":"Characterization of recurrent thrombosis in pediatric antiphospholipid syndrome","volume":"97","author":"Avila","year":"2022","journal-title":"Am J Hematol"},{"issue":"2","key":"2026062308463852200_bib64","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/rheumatology\/ket313","article-title":"Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)","volume":"53","author":"Cuadrado","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"2026062308463852200_bib65","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/TA.0000000000001404","article-title":"Evaluation of guidelines for injured children at high risk for venous thromboembolism: a prospective observational study","volume":"82","author":"Landisch","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"2026062308463852200_bib66","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1097\/MPH.0000000000002167","article-title":"Use of pharmacologic prophylaxis against venous thromboembolism in hospitalized injured children","volume":"44","author":"Mahajerin","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"2026062308463852200_bib67","first-page":"52","article-title":"Incidence and risk factors for venous thromboembolism in critically ill children after trauma","volume":"68","author":"Hanson","year":"2010","journal-title":"J Trauma"},{"issue":"1","key":"2026062308463852200_bib68","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00383-023-05540-9","article-title":"Thromboprophylaxis in pediatric patients with earthquake-related crush syndrome: a single centre experience","volume":"39","author":"Karahan","year":"2023","journal-title":"Pediatr Surg Int"},{"issue":"1","key":"2026062308463852200_bib69","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/TA.0000000000003797","article-title":"Venous thromboembolic screening in pediatric trauma: a prospective cohort study of risk-stratified ultrasonography","volume":"94","author":"Tobias","year":"2023","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"2026062308463852200_bib70","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/TA.0b013e31824964d1","article-title":"Effectiveness of clinical guidelines for deep vein thrombosis prophylaxis in reducing the incidence of venous thromboembolism in critically ill children after trauma","volume":"72","author":"Hanson","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"issue":"8","key":"2026062308463852200_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26415","article-title":"Venous thromboembolism in pediatric trauma patients: ten-year experience and long-term follow-up in a tertiary care center","volume":"64","author":"Leeper","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2026062308463852200_bib72","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.burns.2018.09.032","article-title":"Incidence and risk factors for deep vein thrombosis among pediatric burn patients","volume":"45","author":"Alturki","year":"2019","journal-title":"Burns"},{"issue":"9","key":"2026062308463852200_bib73","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1097\/PCC.0000000000001614","article-title":"Multicenter review of current practices associated with venous thromboembolism prophylaxis in pediatric patients after trauma","volume":"19","author":"Bigelow","year":"2018","journal-title":"Pediatr Crit Care Med"},{"issue":"10","key":"2026062308463852200_bib74","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jamasurg.2024.2487","article-title":"Venous thromboembolism prophylaxis in high-risk pediatric trauma patients","volume":"159","author":"Witte","year":"2024","journal-title":"JAMA Surg"},{"issue":"1","key":"2026062308463852200_bib75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamasurg.2015.2670","article-title":"A clinical tool for the prediction of venous thromboembolism in pediatric trauma patients","volume":"151","author":"Connelly","year":"2016","journal-title":"JAMA Surg"},{"issue":"5","key":"2026062308463852200_bib76","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/MPG.0000000000003231","article-title":"Safety of venous thromboprophylaxis with low-molecular-weight heparin in children with ulcerative colitis","volume":"73","author":"Story","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"2026062308463852200_bib77","doi-asserted-by":"crossref","first-page":"e2337789","DOI":"10.1001\/jamanetworkopen.2023.37789","article-title":"Model-guided decision-making for thromboprophylaxis and hospital-acquired thromboembolic events among hospitalized children and adolescents: the CLOT Randomized Clinical Trial","volume":"6","author":"Walker","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2026062308463852200_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(22)60566-3","article-title":"Prophylactic enoxaparin fails to prevent thrombosis in high-risk pediatric inflammatory bowel disease patients","volume":"162","author":"Levine","year":"2022","journal-title":"Gastroenterology"},{"key":"2026062308463852200_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2019.02.001","article-title":"Primary thromboprophylaxis in hospitalized children: a multi-center retrospective analysis","volume":"176","author":"Amos","year":"2019","journal-title":"Thromb Res"},{"key":"2026062308463852200_bib80","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2021.10.024","article-title":"Validation of risk assessment models for venous thromboembolism and bleeding in critically ill adolescents","volume":"208","author":"Gupta","year":"2021","journal-title":"Thromb Res"},{"issue":"2","key":"2026062308463852200_bib81","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/PCC.0000000000003383","article-title":"Hospital-acquired venous thromboembolism and invasive mechanical ventilation: a report from the Children's Hospital Acquired Thrombosis Consortium","volume":"25","author":"Sochet","year":"2024","journal-title":"Pediatr Crit Care Med"},{"issue":"7","key":"2026062308463852200_bib82","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00383-016-3902-5","article-title":"Quality improvement program reduces venous thromboembolism in infants and children with long-gap esophageal atresia (LGEA)","volume":"32","author":"Kelly","year":"2016","journal-title":"Pediatr Surg Int"},{"issue":"8","key":"2026062308463852200_bib83","doi-asserted-by":"crossref","first-page":"e0237016","DOI":"10.1371\/journal.pone.0237016","article-title":"Clinical course and short-term outcome of postsplenectomy reactive thrombocytosis in children without myeloproliferative disorders: a single institutional experience from a developing country","volume":"15","author":"Zvizdic","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"2026062308463852200_bib84","doi-asserted-by":"crossref","first-page":"e28803","DOI":"10.1002\/pbc.28803","article-title":"Optimizing pharmacologic thromboprophylaxis use in pediatric orthopedic surgical patients through implementation of a perioperative venous thromboembolism risk screening tool","volume":"68","author":"MacNevin","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"29","key":"2026062308463852200_bib85","doi-asserted-by":"crossref","first-page":"e16552","DOI":"10.1097\/MD.0000000000016552","article-title":"Is pharmacological anticoagulant prophylaxis necessary for adolescent idiopathic scoliosis surgery?","volume":"98","author":"Kochai","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"2026062308463852200_bib86","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/BPO.0000000000001798","article-title":"Venous thromboembolism after pelvic osteotomy in adolescent patients: a database study characterizing rates and current practices","volume":"41","author":"Allahabadi","year":"2021","journal-title":"J Pediatr Orthop"},{"key":"2026062308463852200_bib87","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","article-title":"GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT","volume":"81","author":"Sch\u00fcnemann","year":"2017","journal-title":"J Clin Epidemiol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/12\/4303\/2527704\/blooda_adv-2025-019415-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/12\/4303\/2527704\/blooda_adv-2025-019415-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:46:54Z","timestamp":1782218814000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/12\/4303\/567385\/ASH-ISTH-2026-guidelines-for-anticoagulant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":87,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,6,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025019415","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,23]]},"published":{"date-parts":[[2026,6,12]]}}}